Biosensor with its heartstent biz shd be good as it is recession proofââ¬Â¦shd turn around for FYE 31 mar 2009ââ¬Â¦receive USD 40mil from a licensee offset by non recurring restructuring charges for the US and netherlands ops..shd turn around even if exclude the one time capital gainââ¬Â¦linited downside 35cts..upside at least 55cts:P
If got patience sure make limited downside from here the worst drop back to 35cts and then bounced back again...one of my favourites previously and even now..short and long can make $$$ but now long...till it move up...bank interest
Biosensers without stents to market and yearly losses of more than US$40m, share price trade as high as over $1.40. When it received it\'s CE Mark in January 2008 for it\'s flag ship BioMatrix, it\'s share price trade as high as $1.10 but company still in the red. Now after 1 year of much growth in BioMatrix stents, company alrady in the black and the future looks bright but share price still below 60cts. What going on?????????:ohmy:
Got in rather late but I think Biosensors has attractive valuation. Biosensors trades at 12x FY2012 earnings. Cool for a cool stock. Hoping for more upside from $1.49 now.